Roundview Capital LLC decreased its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 22.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 33,150 shares of the pharmacy operator’s stock after selling 9,490 shares during the period. Roundview Capital LLC’s holdings in Walgreens Boots Alliance were worth $2,407,000 as of its most recent filing with the SEC.
Several other hedge funds also recently made changes to their positions in WBA. LSV Asset Management raised its stake in Walgreens Boots Alliance by 38,624.0% in the 4th quarter. LSV Asset Management now owns 3,678,780 shares of the pharmacy operator’s stock worth $267,153,000 after purchasing an additional 3,669,280 shares in the last quarter. Franklin Resources Inc. raised its stake in Walgreens Boots Alliance by 24.7% in the 2nd quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock worth $1,448,939,000 after purchasing an additional 3,662,302 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its stake in Walgreens Boots Alliance by 471.4% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,295,583 shares of the pharmacy operator’s stock worth $258,077,000 after purchasing an additional 2,718,800 shares in the last quarter. Vanguard Group Inc. raised its position in shares of Walgreens Boots Alliance by 2.8% in the 2nd quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock valued at $5,480,577,000 after buying an additional 1,926,108 shares in the last quarter. Finally, CI Global Investments Inc. raised its position in shares of Walgreens Boots Alliance by 32.0% in the 4th quarter. CI Global Investments Inc. now owns 7,373,589 shares of the pharmacy operator’s stock valued at $535,470,000 after buying an additional 1,785,449 shares in the last quarter. 61.57% of the stock is owned by institutional investors and hedge funds.
In related news, insider Stefano Pessina acquired 98,858 shares of the stock in a transaction that occurred on Monday, January 15th. The stock was acquired at an average cost of $76.07 per share, for a total transaction of $7,520,128.06. The transaction was disclosed in a filing with the SEC, which is available through this link. 14.80% of the stock is owned by corporate insiders.
Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $70.92 on Friday. The stock has a market cap of $71,410.00, a P/E ratio of 19.59, a P/E/G ratio of 1.15 and a beta of 1.18. Walgreens Boots Alliance Inc has a 12-month low of $63.82 and a 12-month high of $88.00. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.27 by $0.01. The business had revenue of $30.74 billion during the quarter, compared to analysts’ expectations of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The firm’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the prior year, the company earned $1.10 EPS. analysts anticipate that Walgreens Boots Alliance Inc will post 5.73 earnings per share for the current year.
Walgreens Boots Alliance announced that its board has authorized a share buyback program on Wednesday, October 25th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the pharmacy operator to purchase shares of its stock through open market purchases. Shares buyback programs are generally a sign that the company’s board of directors believes its stock is undervalued.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 12th. Investors of record on Thursday, February 15th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.26%. The ex-dividend date is Wednesday, February 14th. Walgreens Boots Alliance’s dividend payout ratio is 44.20%.
Several equities analysts have recently commented on the stock. Loop Capital set a $90.00 target price on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Tuesday. Royal Bank of Canada restated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Friday. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $76.00 target price for the company in a research report on Wednesday. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, January 10th. Finally, Needham & Company LLC restated a “buy” rating and issued a $88.00 target price (up from $86.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, January 10th. Ten equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $85.05.
TRADEMARK VIOLATION WARNING: This piece of content was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at https://ledgergazette.com/2018/02/17/walgreens-boots-alliance-inc-wba-shares-sold-by-roundview-capital-llc.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.